BPC 157 For Knee Pain: Early Reported Outcomes, A report on intra articular BPC 157 for knee pain described high rates of improvement: ~92% with BPC 157 alone, ~75% when combined with thymosin beta 4, Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The Rising Demand for Peptides Phoenix Pharmaceuticals, Inc. Safety advisory Understanding your responsibilities when importing, compounding and supplying unapproved peptide products We are concerned about the rise in the import, supply, compounding and advertising of unapproved peptide products